Blog

Emre Yekedüz: Our results including more than 20,000 patients were presented as a poster at ESMO23

Photo from Emre Yekedüz/Twitter

Oct 25, 2023, 18:50

Emre Yekedüz: Our results including more than 20,000 patients were presented as a poster at ESMO23

Quoting Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University, on X/Twitter:

”Our results including more than 20,000 patients were presented as a poster at ESMO23. Liver metastasis has the worst prognosis in patient with metastatic hormon-sensitive prostate cancer! Other visceral sites as not bad as liver. Does patients with visceral metastasis to only lung have a high risk disease? We clearly need a new prognostic score in prostate cancer. Many thanks for the outstanding mentoring by Toni Choueiri, Silke Gillessen, Yüksel Ürün and extremely huge contribution and effort by Renee Maria Saliby, Eddy Saad, Marc Eid, Karl Semaan! ”

Source: Emre Yekedüz/Twitter

cancer Eddy Saad Emre Yekedüz ESMO23 Karl Semaan Marc Eid OncoDaily Oncology prostate cancer Renee Maria Saliby Silke Gillessen Toni Choueiri Yüksel Ürün

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 10

OncoThon 2024 Raises $1.3 Million for Pediatric Cancer Research

Richard Sullivan: Do we need a 'new' Geneva Convention and protocols?

Remembering Virgil Abloh: Louis Vuitton’s Creative Director Honored at 41 After His Brave Battle with Cardiac Angiosarcoma

Special Coverage